The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction: a 15-year follow-up study

被引:19
|
作者
Melchior, T [1 ]
Rask-Madsen, C
Torp-Pedersen, C
Hildebrandt, P
Kober, L
Jensen, G
机构
[1] Hillerod Univ Hosp, Dept Cardiol, DK-3400 Hillerod, Denmark
[2] Glostrup Univ Hosp, Dept Cardiol, DK-2600 Glostrup, Denmark
[3] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Copenhagen, Denmark
[4] Frederiksberg Univ Hosp, Dept Cardiol & Endocrinol, DK-2000 Frederiksberg, Denmark
关键词
diabetes mellitus; heart failure; myocardial infarction; mortality; prognosis;
D O I
10.1016/S1388-9842(00)00117-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Information about the occurrence of heart failure in the acute phase of myocardial infarction (MI) in diabetic patients and its impact on prognosis are sparse. Aim: The purpose of the present study was to describe how MI patients with diabetes mellitus (DM) differed from MI patients without DM with respect to the occurrence of heart failure and with respect to the influence of heart failure on mortality during follow-up 30 days extending to 15 years. Methods: The study is a retrospective long-term follow-up of prospectively recorded data concerning 1954 consecutive cases of MI admitted to one coronary care unit (CCU) between 1979 and 1983, DM was diagnosed in 10% (n = 194), with 17% (n = 33) on insulin therapy. Patients with DM comprised of a higher proportion of women (DM 36% vs. no DM 26%, P < 0.001) compared with non-diabetic patients. Baseline risk factors were more prevalent in the patients with DM. The cumulative incidence of heart failure was higher among patients with than without DM (DM 54% vs. no DM 34%, P < 0.001), The incidence of life-threatening arrhythmias were similar in both groups. Only 2% of patients with DM and heart failure survived 10 years of follow-up compared with 15% of the non-diabetic patients with heart failure (P < 0.001). In multivariate analysis DM was not independently associated with 30 days mortality. During long-term follow-up DM was an important risk factor for mortality independent on the presence of heart failure. Conclusion: DM disposes to the development of heart failure. In acute myocardial infarction diabetic patients with heart failure have a worse prognosis than non-diabetic patients with heart failure. (C) 2001 European Society of Cardiology. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [31] Correlation between adipocytokines and AGE products in diabetic and non-diabetic patients with myocardial infarction
    Memon, Anjuman Gul
    Rahman, Muhammad Ataur
    Alghasham, Abdullah
    Hamid, Sadaf
    Hamid, Qamar
    RESEARCH ON CHEMICAL INTERMEDIATES, 2015, 41 (03) : 1625 - 1634
  • [32] Heart rate variability as a means of assessing prognosis after acute myocardial infarction - A 3-year follow-up study
    Quintana, M
    Storck, N
    Lindblad, LE
    Lindvall, K
    Ericson, M
    EUROPEAN HEART JOURNAL, 1997, 18 (05) : 789 - 797
  • [33] The relationship between serum magnesium levels and mortality in non-diabetic hemodialysis patients: A 10-year follow-up study
    Shimohata, Homare
    Yamashita, Marina
    Ohgi, Kentaro
    Tsujimoto, Ryuji
    Maruyama, Hiroshi
    Takayasu, Mamiko
    Hirayama, Kouichi
    Kobayashi, Masaki
    HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 369 - 374
  • [34] Cardiac rehabilitation in patients with myocardial infarction:: a 10-year follow-up study
    Montero, JMM
    Ramírez, RA
    Durán, MDM
    Zarzosa, CD
    Abraira, V
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (10): : 1181 - 1187
  • [35] Prognostic value of fasting glucose on the risk of heart failure and left ventricular systolic dysfunction in non-diabetic patients with ST-segment elevation myocardial infarction
    Hui Wang
    Yang Zhang
    Zhujun Shen
    Ligang Fang
    Zhenyu Liu
    Shuyang Zhang
    Frontiers of Medicine, 2021, 15 : 70 - 78
  • [36] Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study
    H. T. Horsdal
    S. P. Johnsen
    F. Søndergaard
    J. Rungby
    Diabetologia, 2008, 51 : 567 - 574
  • [37] Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study
    Horsdal, H. T.
    Johnsen, S. P.
    Sondergaard, F.
    Rungby, J.
    DIABETOLOGIA, 2008, 51 (04) : 567 - 574
  • [38] Prognostic value of fasting glucose on the risk of heart failure and left ventricular systolic dysfunction in non-diabetic patients with ST-segment elevation myocardial infarction
    Wang, Hui
    Zhang, Yang
    Shen, Zhujun
    Fang, Ligang
    Liu, Zhenyu
    Zhang, Shuyang
    FRONTIERS OF MEDICINE, 2021, 15 (01) : 70 - 78
  • [39] EFFICACY OF STREPTOKINASE IN DIABETIC AND NON-DIABETIC PATIENTS PRESENTING WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION
    Gill, Badar Ul Ahad
    Ramzan, Muhammad
    Ahmed, Nisar
    Abbas, Tariq
    Qureshi, Bilal Ahsan
    Saleemi, Muhammad Sohail
    Zafar, Muhammad Zubair
    Sherwani, Mubashir
    Zaib, Jahan
    PAKISTAN HEART JOURNAL, 2014, 47 (02): : 96 - 99
  • [40] Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients
    Tenerz, Å
    Nilsson, G
    Forberg, R
    Öhrvik, J
    Malmberg, K
    Berne, C
    Leppert, J
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (05) : 494 - 503